BR0014513A - Derivados de etila e propila insubstituìdos por fenóxi de tienoisoxazol úteis como antagonistas de d4 - Google Patents

Derivados de etila e propila insubstituìdos por fenóxi de tienoisoxazol úteis como antagonistas de d4

Info

Publication number
BR0014513A
BR0014513A BR0014513-0A BR0014513A BR0014513A BR 0014513 A BR0014513 A BR 0014513A BR 0014513 A BR0014513 A BR 0014513A BR 0014513 A BR0014513 A BR 0014513A
Authority
BR
Brazil
Prior art keywords
antagonists
ethyl
thienoisoxazole
useful
disorder
Prior art date
Application number
BR0014513-0A
Other languages
English (en)
Portuguese (pt)
Inventor
George E Lee
Timothy A Ayers
John G Jurcak
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BR0014513A publication Critical patent/BR0014513A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR0014513-0A 1999-09-14 2000-09-13 Derivados de etila e propila insubstituìdos por fenóxi de tienoisoxazol úteis como antagonistas de d4 BR0014513A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39615699A 1999-09-14 1999-09-14
PCT/US2000/024949 WO2001019832A2 (en) 1999-09-14 2000-09-13 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists

Publications (1)

Publication Number Publication Date
BR0014513A true BR0014513A (pt) 2002-07-02

Family

ID=23566087

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014513-0A BR0014513A (pt) 1999-09-14 2000-09-13 Derivados de etila e propila insubstituìdos por fenóxi de tienoisoxazol úteis como antagonistas de d4

Country Status (23)

Country Link
EP (1) EP1216249B1 (et)
JP (1) JP4717306B2 (et)
KR (1) KR20020027644A (et)
AR (1) AR032135A1 (et)
AT (1) ATE254620T1 (et)
AU (1) AU7577200A (et)
BR (1) BR0014513A (et)
CA (1) CA2383327C (et)
CZ (1) CZ2002896A3 (et)
DE (1) DE60006698T2 (et)
DK (1) DK1216249T3 (et)
EA (1) EA004177B1 (et)
EE (1) EE200200133A (et)
ES (1) ES2206305T3 (et)
HU (1) HUP0202712A3 (et)
IL (1) IL148522A0 (et)
MX (1) MXPA02002690A (et)
NO (1) NO20021249L (et)
PL (1) PL354481A1 (et)
PT (1) PT1216249E (et)
SK (1) SK3502002A3 (et)
WO (1) WO2001019832A2 (et)
ZA (1) ZA200201760B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
HUP9603001A3 (en) * 1996-10-30 1999-07-28 Richter Gedeon Vegyeszet Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same
DE69936572T2 (de) * 1998-02-09 2008-06-19 Duphar International Research B.V. Benzisoxazolderivate mit d4-antagonistischer wirkung

Also Published As

Publication number Publication date
HUP0202712A2 (hu) 2002-12-28
CZ2002896A3 (cs) 2002-08-14
EE200200133A (et) 2003-04-15
JP4717306B2 (ja) 2011-07-06
DE60006698T2 (de) 2004-09-23
CA2383327C (en) 2009-11-03
DK1216249T3 (da) 2004-03-15
ES2206305T3 (es) 2004-05-16
JP2003509431A (ja) 2003-03-11
ATE254620T1 (de) 2003-12-15
DE60006698D1 (de) 2003-12-24
CA2383327A1 (en) 2001-03-22
AR032135A1 (es) 2003-10-29
EP1216249B1 (en) 2003-11-19
HUP0202712A3 (en) 2004-12-28
ZA200201760B (en) 2003-08-27
IL148522A0 (en) 2002-09-12
MXPA02002690A (es) 2004-09-10
WO2001019832A3 (en) 2001-10-04
NO20021249D0 (no) 2002-03-13
NO20021249L (no) 2002-05-10
PL354481A1 (en) 2004-01-26
EA004177B1 (ru) 2004-02-26
WO2001019832A2 (en) 2001-03-22
PT1216249E (pt) 2004-04-30
SK3502002A3 (en) 2002-09-10
EP1216249A2 (en) 2002-06-26
AU7577200A (en) 2001-04-17
EA200200357A1 (ru) 2002-10-31
KR20020027644A (ko) 2002-04-13

Similar Documents

Publication Publication Date Title
Sala et al. Synthesis and cytotoxic activity evaluation of 2, 3-thiazolidin-4-one derivatives on human breast cancer cell lines
TWI329013B (en) Cannabinoid receptor modulator
JP5514804B2 (ja) ドーパミン神経伝達のモジュレーター
BR0014515A (pt) Derivados de propil tienoisoxazolil- e tienilpirrazolil-fenóxi substituìdos úteis como antagonistas de d4
BRPI0908738A8 (pt) Composto, medicamento, uso de um composto, e, processo para preparar os compostos
BR0014000A (pt) Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4
Toyama et al. Design and synthesis of novel ROR inverse agonists with a dibenzosilole scaffold as a hydrophobic core structure
Morimoto et al. Effective combination of two-directional synthesis and rhenium (VII) chemistry: total synthesis of meso polyether teurilene
US11261154B2 (en) Benzene derivative
Ruano et al. Stereospecific synthesis of highly functionalized tricyclic β-lactams by radical cyclizations using titanocene monochloride
Li et al. Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia
Huang et al. Cerium (IV) ammonium nitrate (CAN)-mediated regioselective synthesis and anticancer activity of 6-substituted 5, 8-dimethoxy-1, 4-naphthoquinone
BR0014513A (pt) Derivados de etila e propila insubstituìdos por fenóxi de tienoisoxazol úteis como antagonistas de d4
US8492372B2 (en) Modulators of dopamine neurotransmission
MX2009007405A (es) Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina.
Anderson et al. Improved synthesis of structural analogues of (−)-epicatechin gallate for modulation of staphylococcal β-lactam resistance
US20110105462A1 (en) Modulators of dopamine neurotransmission
CN106008324A (zh) α,β-不饱和化合物及其应用
EP2389350A1 (en) Methods for making valerenic acid derivatives and their use
Ghuge et al. Therapeutic potential of vicinal diaryl Azetidin-2-ones
CN101723938A (zh) 3-芳(杂)-6,8-二羟基异黄酮类化合物合成工艺及生物活性
EA200701052A1 (ru) Новые производные замещённого арилпиперазина
EA200970672A1 (ru) Соединения с комбинацией каннабиноид-свантагонизма и ингибирования обратного захвата серотонина
MX2023004116A (es) Nuevos compuestos potentes y selectivos como moduladores del receptor de serotonina 1b.
CN104470894A (zh) 新吡咯烷衍生物

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.